Skip to content
Screener

Precigen PGEN Q1 2025 Annual earnings

Reported May 14, 2025 · Before market open

Revenue$1.3MBeat by $841.0K
EPS-$0.07Beat by $0.01
Revenue estimate$500.0K
EPS estimate-$0.08

Next report

Nov 12, 2026 (in 2 months)
Revenue estimate$69.2M
EPS estimate$0.09

Financials

Q1 2025

Income statement

See full
Revenue$1.3M+36.7%
Operating income-$22.6M+33.1%
Net income-$54.2M-128%
EPS (diluted)-$0.18-80.0%

Balance sheet

See full
Cash & equivalents$6.1M-65.9%
Total debt$5.4M-19.2%
Total equity-$14.1M-114%
Total assets$128.8M-4.5%

Cash flow

See full
Operating cash flow-$16.3M-15.9%
CapEx$622.0K-85.7%
Free cash flow-$16.9M+8.1%

Valuation & ratios

Valuation

as of 03/31/25
See full
Market cap$438.12M+21.2%
Enterprise value$437.48M+24.9%
P/S102.3×—

Profitability

See full
Operating margin-2,890.9%—
Net margin-3,656%—
FCF margin-1,756.5%—

Returns & leverage

See full
Current ratio3.5×+1.8×

FAQ

When did Precigen report Q1 2025 earnings?
Precigen (PGEN) reported Q1 2025 earnings on May 14, 2025 before market open.
What were Precigen's Q1 2025 revenue and EPS?
Precigen reported revenue of $1.3M and eps of $-0.07 for Q1 2025.
Did Precigen beat estimates in Q1 2025?
Revenue beat the consensus estimate of $500.0K by $841.0K. EPS beat the consensus estimate of $-0.08 by $0.01.
How did Precigen's Q1 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 25.9% from $1.1M a year earlier and eps grew 30.0% from $-0.10.
Where can I find Precigen's Q1 2025 SEC filings?
You can read the 8-K earnings release (0000950103-25-006004) and the 10-K/A periodic report (0001356090-25-000011) directly on SEC EDGAR. The filing index links above go to sec.gov.